TIBCO Expands Strategic Spotfire Relationship With PerkinElmer to Include Clinical Research and Development Market

TIBCO Expands Strategic Spotfire Relationship With PerkinElmer to Include 
Clinical Research and Development Market 
PerkinElmer Gains Exclusive Rights to the Global Clinical Research
and Development Market 
LAS VEGAS, NV -- (Marketwired) -- 10/16/13 --  TIBCO Software Inc.
(NASDAQ: TIBX), the provider of TIBCO Spotfire(R), a leading
analytics and data discovery platform, today announced it has
expanded its relationship with PerkinElmer, Inc., a global leader
focused on improving the health and safety of people and the
environment, a year after previously launching their successful
scientific research and development relationship. 
The expanded alliance will allow customers to benefit from
substantially larger investments in product and application
development from PerkinElmer, fostering collaboration and integration
between discovery research and clinical development. The early
success that PerkinElmer has had in the Global Research Market (GRM)
has evolved into an industry benchmark that necessitates applications
that provide out-of-the-box functionality. This relationship not only
addresses those needs, but serves the increasing interest in the
translational approach to medicine. 
"We are extremely excited by a part of this unique relationship with
PerkinElmer," said Matt Quinn, chief technology officer, TIBCO.
"Joining forces strengthens our vertical industry focus on
pharmaceuticals and biotech -- as well as many others -- while giving
TIBCO the means and capacity to focus on, and successfully invest in,
expansion into other verticals and horizontals." 
"Through this expanded strategic relationship, we are very excited to
offer scientists a complete package of data generation, data
management, plus data analysis and visualization, so they can better
harness information for more informed insights and decisions in the
clinical space," said Mike Stapleton, general manager, informatics,
PerkinElmer. "TIBCO Spotfire complements PerkinElmer's informatics
offerings by adding search and data visualization, which are among
life science laboratories' most pressing business needs." 
Additionally, within this relationship, PerkinElmer becomes the
exclusive TIBCO channel for TIBCO Spotfire in clinical research and
development applications, including the testing (clinical trials,
studies and research) of human populations to determine the safety
and efficacy of medications, devices, diagnostic products and
treatment regimens, pre-approval (phases 1-3) and post-approval
(phase 4) clinical trials, operational data on trial execution,
safety risk monitoring (pre and post marketing pharmacovigilance),
and adverse event tracking.  
For more information on this relationship and TIBCO Software Inc.,
please visit the www.tibco.com.  
 TIBCO Software Inc. (NASDAQ: TIBX) is a provider of
infrastructure software for companies to use on-premise or as part of
cloud computing environments. Whether it's optimizing claims,
processing trades, cross-selling products based on real-time customer
behavior, or averting a crisis before it happens, TIBCO provides
companies the Two-Second Advantage(R) - the ability to capture the
right information at the right time and act on it preemptively for a
competitive advantage. More than 4,000 customers worldwide rely on
TIBCO to manage information, decisions, processes and applications in
real time. Learn more at www.tibco.com. 
About PerkinElmer
 PerkinElmer, Inc. is a global leader focused on
improving the health and safety of people and the environment. The
company reported revenue of approximately $2.1 billion in 2012, has
about 7,500 employees serving customers in more than 150 countries,
and is a component of the S&P 500 Index. Additional information is
available through 1-877-PKI-NYSE, or at www.perkinelmer.com. 
TIBCO, TIBCO Software, Spotfire and Two-Second Advantage are
trademarks or registered trademarks of TIBCO Software Inc. or its
subsidiaries in the United States and/or other countries. Other
product and company names and marks mentioned in this document are
the property of their respective owners and are mentioned for
identification purposes only. 
Media Contact:
Leslie Moore
TIBCO Software Inc.
(650) 846-5025
Press spacebar to pause and continue. Press esc to stop.